Variables | Coefficient (95% CI) | p-value⊥ | Adjusted R2 |
---|---|---|---|
Clinical/demographic | |||
Gender (male) | 0.32 (0.03, 0.60) | 0.030 | 0.178 |
Treatment response | −0.46 (−0.65, −0.27) | <0.001 | 0.178 |
HAQ | −0.73 (−0.97, −0.49) | <0.001 | 0.178 |
Pain (VAS) | −0.04 (−0.11, 0.03) | 0.316 | 0.177 |
Fatigue (VAS) | −0.06 (−0.12, 0.01) | 0.083 | 0.182 |
PGA | −0.01 (−0.08, 0.07) | 0.733 | 0.182 |
PhGA | −0.01 (−0.11, 0.09) | 0.607 | 0.175 |
SF-36 | |||
MCS | 0.31 (0.19, 0.43) | <0.001 | 0.230 |
Vitality | 0.16 (0.08, 0.24) | <0.001 | 0.210 |
Social function | 0.08 (0.02, 0.15) | 0.008 | 0.191 |
Mental health | 0.21 (0.13, 0.28) | <0.001 | 0.235 |
Role emotional | 0.07 (0.04, 0.10) | <0.001 | 0.218 |
IPQ-R | |||
Illness coherence | 0.07 (0.04, 0.10) | <0.001 | 0.215 |
Treatment control | 0.09 (0.03, 0.14) | 0.002 | 0.197 |
Personal control | 0.05 (0.01, 0.09) | 0.008 | 0.191 |
Emotional representations | −0.07 (−0.10, −0.05) | <0.001 | 0.261 |
Consequences | −0.07 (−0.10, −0.03) | <0.001 | 0.208 |
UCL | |||
Passive reacting | −0.08 (−0.12, −0.04) | <0.001 | 0.186 |
Active tackling | 0.03 (−0.01, 0.07) | 0.090 | 0.182 |
RAQoL | −0.04 (−0.07, −0.02) | 0.001 | 0.199 |